Electrolyte supplement / anticonvulsant / bronchodilator

14 marketed 2 in Phase 3

This page covers all Electrolyte supplement / anticonvulsant / bronchodilator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting NMDA receptor, voltage-gated calcium channels, NMDA receptor antagonist; calcium channel blocker, Voltage-gated calcium channels, NMDA receptor.

Targets

NMDA receptor, voltage-gated calcium channels · NMDA receptor antagonist; calcium channel blocker · Voltage-gated calcium channels, NMDA receptor · Voltage-gated calcium channels, NMDA receptors · Neuromuscular junction (calcium channel antagonist at motor endplate) · Potassium ion (K+) / Na+/K+-ATPase pump · NMDA receptor, L-type calcium channels · NMDA receptor; voltage-gated calcium channels · NMDA receptor antagonist; calcium channel blocker (non-selective) · NMDA receptor antagonist; calcium channel modulator

Marketed (14)

Phase 3 pipeline (2)

Patent intelligence